HCA Healthcare, Inc. (HCA)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $106.91B
Last updated: Nov 17, 2026 at 4:34 PM ET
HCA Healthcare, Inc. (HCA) Statistics
HCA Healthcare (HCA) has a market cap of $106.91B and an enterprise value of $156.49B. Its share count is down 7.86% from a year earlier. Its return on invested capital of 22.82% compares with a 10.68% median across 10 similar companies.
Total Valuation
Enterprise value is 46.38% above the market cap, as debt exceeds cash.
| Market Cap | $106.91B |
|---|---|
| Enterprise Value | $156.49B |
| Latest price (Nov 17, 2026) | $501.03 |
Key Dates
The next earnings report is expected on Jan 25, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 15, 2026.
| Next Earnings Date | Jan 25, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 27, 2026 |
| Next Ex-Dividend Date | Dec 15, 2026 |
| Next Payment Date | Dec 29, 2026 |
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 1.4x. Its year-end P/E ranged from 10.8x to 16.6x from 2016 to 2025.
| P/E Ratio | 16.7x |
|---|---|
| Forward P/E | 16.4x |
| P/S Ratio | 1.4x |
| Forward P/S | 1.4x |
| P/FCF Ratio | 18.0x |
| P/OCF Ratio | 9.6x |
| PEG Ratio | 1.7 |
Enterprise Valuation
Counting debt and cash, the company is valued at 9.8x EBITDA and 26.3x free cash flow.
| EV / Earnings | 20.1x |
|---|---|
| EV / Sales | 2.0x |
| EV / EBITDA | 9.8x |
| EV / EBIT | 12.8x |
| EV / FCF | 26.3x |
Price Statistics
The stock is up 6.54% over 52 weeks and trades 9.68% above its 50-day average.
| Beta (1Y) | 0.25 |
|---|---|
| 52-Week Change | +6.54% |
| 1-Month Change | +10.15% |
| 3-Month Change | +23.31% |
| 6-Month Change | +24.27% |
| 5-Year Change | +88.93% |
| 10-Year Change | +518.31% |
| Total Return (1Y) | +7.19% |
| Total Return (3Y CAGR) | +27.57% |
| Total Return (5Y CAGR) | +16.48% |
| Return vs SPY (1Y) | -6.25% |
| Max Drawdown (1Y) | -33.74% |
| Max Drawdown (3Y) | -33.74% |
| Sharpe Ratio (1Y) | 0.16 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $456.81 |
| 200-Day Average | $444.57 |
| 52-Week Range | $353.34 to $553.56 |
| RSI (14 Days) | 59.5 |
| Average Volume (20 Days) | 1.41M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.82x current liabilities.
| Current Ratio | 0.82x |
|---|---|
| Quick Ratio | 0.74x |
| Debt / EBITDA | 3.16x |
| Debt / FCF | 8.45x |
| Interest Coverage | 5.16x |
Returns and Efficiency
Return on invested capital is 22.82% over the last 12 months, against a 5-year average of 22.77%.
| Return on Assets (ROA) | 12.29% |
|---|---|
| Return on Invested Capital (ROIC) | 22.82% |
| Return on Capital Employed (ROCE) | 27.92% |
| ROA (5Y Average) | 12.62% |
| ROIC (5Y Average) | 22.77% |
| Asset Turnover | 1.28x |
| Inventory Turnover | 26.94x |
| Receivables Turnover | 6.62x |
| Cash Conversion Cycle | 29 days |
Taxes
Income tax took 20.60% of pretax income over the last 12 months.
| Income Tax (TTM) | $2.02B |
|---|---|
| Effective Tax Rate | 20.60% |
Scores
HCA has an Altman Z-Score of 2.58, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.58 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $78.70B over the last 12 months is up 5.82% from the 12 months before.
| Revenue | $78.70B |
|---|---|
| Revenue Growth (YoY) | +5.82% |
| Gross Profit | $33.82B |
| Operating Income | $12.19B |
| Pretax Income | $9.82B |
| Net Income | $7.80B |
| EBITDA | $15.98B |
| EBIT | $12.19B |
| Reported EPS (TTM) | $29.97 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $908.00M |
|---|---|
| Total Debt | $50.49B |
| Net Debt | $49.59B |
| Net Debt Per Share | $231.07 |
| Working Capital | -$3.56B |
| Shareholder Equity | -$8.08B |
| Tangible Book Value | -$19.28B |
| Total Assets | $63.45B |
| Total Liabilities | $68.05B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $5.20B of capital spending, operating cash flow left $5.97B of free cash flow.
| Operating Cash Flow | $11.17B |
|---|---|
| Capital Expenditures | $5.20B |
| Free Cash Flow | $5.97B |
| FCF Per Share | $27.59 |
| Depreciation and Amortization | $3.79B |
| Dividends Paid | $1.45B |
| Share Repurchases | $9.16B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 15.49%, against a 5-year average of 16.44%.
| Gross Margin | 42.97% |
|---|---|
| Operating Margin | 15.49% |
| Pretax Margin | 12.48% |
| Net Margin | 9.91% |
| EBITDA Margin | 20.30% |
| EBIT Margin | 15.49% |
| FCF Margin | 7.59% |
| Gross Margin (5Y Average) | 55.12% |
| Operating Margin (5Y Average) | 16.44% |
| Net Margin (5Y Average) | 10.72% |
Growth
Revenue grew 7.87% a year over 3 years, and EPS 18.69% a year.
| Revenue Growth (3Y CAGR) | +7.87% |
|---|---|
| Revenue Growth (5Y CAGR) | +7.97% |
| EPS Growth (3Y CAGR) | +18.69% |
| EPS Growth (5Y CAGR) | +23.39% |
| FCF Growth (3Y CAGR) | +23.07% |
| FCF Growth (5Y CAGR) | +3.76% |
| Operating Income Growth (3Y CAGR) | +5.27% |
Dividends and Yields
HCA pays out 5.88% of earnings as dividends.
| Dividend Per Share (Annual) | $3.12 |
|---|---|
| Dividend Yield | 0.62% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +8.74% |
| Dividend Growth (5Y CAGR) | +30.19% |
| Payout Ratio | 5.88% |
| FCF Payout Ratio | 24.29% |
| Earnings Yield | 5.99% |
| FCF Yield | 5.56% |
| Buyback Yield | 8.52% |
| Shareholder Yield | 9.87% |
Peer Position
Against 10 similar companies, HCA has the 6th highest P/E and the 4th highest P/S.
P/E RatioPeer median 19.5x
P/S RatioPeer median 1.0x
ROICPeer median 10.68%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.48%
Dividend YieldPeer median 0.21%
| P/E Ratio | 16.7x vs 19.5x median |
|---|---|
| P/S Ratio | 1.4x vs 1.0x median |
| ROIC | 22.82% vs 10.68% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +5.82% vs +6.48% median |
| Dividend Yield | 0.62% vs 0.21% median |
Analyst Forecast
Consensus estimates put revenue growth at 3.93% and EPS growth at 5.24% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +3.93% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +5.24% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About HCA
What is HCA's market cap?
HCA Healthcare has a market cap of $106.91B. Its enterprise value, which adds debt and subtracts cash, is $156.49B.
What is HCA's P/E ratio?
HCA Healthcare has a trailing P/E ratio of 16.7x and a forward P/E of 16.4x.
How many shares of HCA are outstanding?
HCA Healthcare has 214.59M shares outstanding. The count is down 7.86% from a year earlier.
Does HCA pay a dividend?
Yes. HCA Healthcare pays $3.12 a share a year, a dividend yield of 0.62%.
How much debt does HCA have?
HCA Healthcare has $50.49B of total debt and $908.00M of cash and equivalents, a net debt position of $49.59B.
HCA pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors